← Eichor
Condition: Pseudomyxoma Peritonei Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Pseudomyxoma Peritonei

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
Phase 2 · 2 location(s) · Prakash Pandalai · NCT04779554
Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis
NA · 1 location(s) · Institut du Cancer de Montpellier - Val d'Aurelle · NCT04024917
Metronomic Neoadjuvant Capecitabine and Cyclophosphamide in HUGE Pseudomyxoma Peritonei Patients
Phase 2 · 1 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06800391
Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)
Phase 3 · 1 location(s) · University of Southampton · NCT06513065
Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms
Phase 2 · 1 location(s) · University of California, Irvine · NCT07693452
Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies
Phase N/A · 1 location(s) · Oslo University Hospital · NCT02073500
Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.
Phase N/A · 1 location(s) · Jules Bordet Institute · NCT07451483
Pseudovax - A Cancer Vaccine for Patients With Pseudomyxoma Peritonei
EARLY_Phase 1 · 1 location(s) · Oslo University Hospital · NCT07341360
One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei
NA · 1 location(s) · Beijing Tsinghua Chang Gung Hospital · NCT07328737
Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surger
Phase 3 · 1 location(s) · CSL Behring · NCT06617897
Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed
Phase N/A · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT01617382
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.